Miconia willdenowii
Miconia willdenowii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Miconia willdenowii is a botanical species currently being investigated for its diverse pharmacological potential. Recent studies have focused on evaluating the antimicrobial activities of its crude ethanolic extract. Researchers have specifically targeted the efficacy of this preparation against the pathogen Staphylococcus aureus. Central to this biological activity is the presence of the chemical compound primin. Understanding these interactions provides valuable insights into the plant's medicinal properties.
- Synonyms
- Acinodendron Willdenowii · Miconia Argyraea · 1 more
- Common names
- Not available
- Family
- Melastomataceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Miconia willdenowii is a botanical species that is frequently identified by several different scientific names. Due to shifting taxonomic classifications, it is often listed under the synonym Acinodendron argyraeum. Researchers also encounter this plant documented as Acinodendron willdenowii in various historical records. Furthermore, the name Miconia argyraea serves as another recognized synonym for this specific taxon. Understanding these overlapping designations is essential for maintaining accurate botanical documentation.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Miconia willdenowii is a distinctive species belonging to the vast kingdom Plantae. Within this biological kingdom, it is classified under the class Equisetopsida. Its taxonomic lineage continues through the order Myrtales, which defines many of its structural characteristics. This plant is a member of the diverse Melastomataceae family, showcasing unique floral traits. Ultimately, it is identified by its specific genus, Miconia, which places it among its closest botanical relatives.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Melastomataceae |
| Genus | Miconia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Miconia willdenowii is a notable plant species primarily found throughout the vast landscapes of Southern America. Its natural distribution is most heavily concentrated within the borders of Brazil, where it thrives in diverse ecosystems. Specifically, the plant is well-established in the southern regions of the country, showing a strong presence in these tropical environments. Furthermore, it can be frequently identified across the southeastern parts of Brazil as well. This wide geographic reach within South America highlights the species' adaptability to the local climate.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Miconia willdenowii is a self-supporting plant that adopts a distinct tree-like growth form. While its stature can vary, it typically reaches a maximum height of 2.5 meters in many environments. However, under optimal conditions, this species is capable of climbing to a maximum height of 7 meters. This impressive vertical range allows it to establish a significant presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Miconia willdenowii has emerged as a promising medicinal plant from the Brazilian Atlantic Forest due to its significant antimicrobial properties. Recent studies demonstrate that crude ethanolic extracts of this species can effectively inhibit various pathogenic fungi as well as both Gram-positive and Gram-negative bacteria. Specifically, the plant's hexane fraction has shown notable activity against microbes such as Staphylococcus aureus and Candida krusei. Researchers have identified the metabolite primin as the likely bioactive compound responsible for these diverse antimicrobial effects. This discovery marks the first formal report of the antimicrobial and anti-leishmanicidal potential inherent in Miconia willdenowii.
Compounds
Miconia willdenowii has emerged as a significant subject of study within bioprospecting efforts in the Brazilian Atlantic Forest due to its potent medicinal properties. Research indicates that this plant contains the bioactive metabolite known as primin, which is found within its hexane fraction. This specific compound demonstrates remarkable leishmanicidal activity, even surpassing the potency of the standard drug amphotericin B against certain protozoan forms. Additionally, primin exhibits strong antimicrobial effects against various pathogenic fungi and bacteria, such as Staphylococcus aureus. These findings highlight the importance of Miconia willdenowii as a rich source of natural compounds for future pharmacological development.
Conditions
Miconia willdenowii exhibits significant antimicrobial properties against both Gram positive and negative bacteria. This plant specifically treats Staphylococcus aureus, demonstrating potent activity against this pathogen. Furthermore, Miconia willdenowii effectively treats Candida krusei. Its medicinal value extends to pathogenic fungi, showing broad efficacy in this category. Ultimately, the plant treats all tested fungi species through its bioactive metabolites.
Preparations
Miconia willdenowii is prepared as a crude ethanolic extract to investigate its medicinal potential. This specific preparation demonstrated a remarkable 99.7% inhibition of Leishmania amazonensis promastigotes at a concentration of 80 μg/mL. Beyond its leishmanicidal properties, the extract also exhibited significant antimicrobial activity against various pathogenic fungi and bacteria. Subsequent bioguided studies on fractions of this extract led to the identification of primin as a key bioactive metabolite. Ultimately, the use of the crude ethanolic extract provided the first reported evidence of the plant's antimicrobial and anti-leishmanial effects.